SCHEMBL8015239

SCHEMBL8015239

CCCCCCCCCCCCSCC(NC(=O)OC(C)(C)C)C(=O)O.O=C(CCl)CCl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.47
PPARA Q07869 9/20 0.47
CYP2C9 P11712 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46
PPARD Q03181 2/20 0.46
CTSK P43235 5/20 0.43
CTSS P25774 3/20 0.43
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23117326 0.93 PPARG (0.53) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL7757488 0.93 PPARG (0.53) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL8015241 0.91 PPARG (0.49) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL7430468 0.88 PPARG (0.55) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL7762822 0.85 GMNN (0.39) CYP2C9MAPTGMNNTP53POLB
SCHEMBL21153885 0.82 PPARA (0.57) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL6484104 0.82 PPARA (0.57) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL13855559 0.82 CTSK (0.47) PPARGPPARACYP2C9CYP1A2CYP2C19
SCHEMBL7763906 0.81 CES1 (0.46) CYP2C9MAPTGMNNTP53POLB
SCHEMBL15703381 0.80 CYP1A2 (0.50) PPARGPPARACYP2C9CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6015877-A ANTICARCINOGENIC AGENT WHICH INHIBITS ENDOPROTEASE ACTIVITY DIRECTED AGAINST SPECIFIC CYSTEINE CONTAINING CARBOXY TERMINAL MOTIF FOUND IN RAS PROTEINS AND OTHER SIGNAL TRANSDUCING G PROTEINS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2000-01-18 US claimed